GLP1R and Parkinson disease: In addition, leave-one-out sensitivity analysis revealed that on excluding the study NET.PD et al., the outcome MATTIS-DRS becomes statistically significant favoring the interventional group indicating potential efficacy of GLP-1 agonists in improving the dementia rating scale (Supplementary Fig. 4).